Janux Therapeutics News

Janux Therapeutics Analyst Ratings

BenzingaMay 30 10:36 ET

Analysts Offer Insights on Healthcare Companies: Valneva (VALN), Janux Therapeutics Inc (JANX) and Kymera Therapeutics (KYMR)

TipRanksMay 13 09:40 ET

Janux Therapeutics Analyst Ratings

BenzingaMay 13 07:17 ET

Buy Rating Affirmed for Janux Therapeutics With Revised Higher Price Target Amidst Strong Financials and Promising Clinical Trials

TipRanksMay 13 06:21 ET

Janux Therapeutics Analyst Ratings

BenzingaMay 9 10:18 ET

Janux Therapeutics: Promising Early Data for EGFR-Targeted Therapies Warrants a Buy Rating

TipRanksMay 9 08:05 ET

Janux Therapeutics Analyst Ratings

BenzingaMay 8 10:41 ET

Wedbush Maintains Outperform on Janux Therapeutics, Raises Price Target to $74

BenzingaMay 8 10:43 ET

Janux Therapeutics Inc (JANX) Gets a Buy From Wedbush

TipRanksMay 8 08:27 ET

Janux Therapeutics Analyst Ratings

BenzingaApr 16 06:49 ET

Buy Rating Affirmed for Janux Therapeutics on Innovative Oncology Treatments and M&A Potential

TipRanksApr 15 16:15 ET

Analysts' Top Healthcare Picks: Humacyte (HUMA), Janux Therapeutics Inc (JANX)

TipRanksApr 10 21:10 ET

Janux Therapeutics Analyst Ratings

BenzingaMar 21 05:58 ET

Janux Therapeutics Analyst Ratings

BenzingaMar 20 05:22 ET

Janux Therapeutics Analyst Ratings

BenzingaMar 13 10:30 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Janux Therapeutics Inc (JANX) and SAGE Therapeutics (SAGE)

TipRanksMar 11 06:50 ET

Janux Therapeutics Analyst Ratings

BenzingaMar 11 06:23 ET

Janux Therapeutics Analyst Ratings

BenzingaFeb 27 08:54 ET

Buy Rating Affirmed for Janux Therapeutics on Strong Clinical Data and Advanced TRACTr Platform

TipRanksFeb 27 06:27 ET

Janux Therapeutics Analyst Ratings

BenzingaNov 13, 2023 10:43 ET